11.54
price down icon0.52%   -0.06
after-market Handel nachbörslich: 11.54
loading
Schlusskurs vom Vortag:
$11.60
Offen:
$11.33
24-Stunden-Volumen:
1.69M
Relative Volume:
0.62
Marktkapitalisierung:
$1.32B
Einnahmen:
$631.73M
Nettoeinkommen (Verlust:
$-239.78M
KGV:
-5.7129
EPS:
-2.02
Netto-Cashflow:
$-33.45M
1W Leistung:
-0.52%
1M Leistung:
-8.70%
6M Leistung:
+39.46%
1J Leistung:
-29.07%
1-Tages-Spanne:
Value
$11.16
$11.76
1-Wochen-Bereich:
Value
$11.16
$12.14
52-Wochen-Spanne:
Value
$6.78
$18.21

10 X Genomics Inc Stock (TXG) Company Profile

Name
Firmenname
10 X Genomics Inc
Name
Telefon
(925) 401-7300
Name
Adresse
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
Mitarbeiter
1,306
Name
Twitter
@10xgenomics
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
TXG's Discussions on Twitter

Vergleichen Sie TXG mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Health Information Services icon
TXG
10 X Genomics Inc
11.54 1.43B 631.73M -239.78M -33.45M -2.02
Health Information Services icon
VEEV
Veeva Systems Inc
287.65 46.89B 2.97B 809.93M 1.33B 4.8743
Health Information Services icon
TEM
Tempus Ai Inc
89.87 16.41B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
DOCS
Doximity Inc
67.03 12.64B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
HQY
Healthequity Inc
94.04 8.03B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
36.62 6.90B 906.14M -52.62M 89.62M -0.3621

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-11 Eingeleitet Piper Sandler Neutral
2025-02-13 Herabstufung Leerink Partners Outperform → Market Perform
2024-09-03 Eingeleitet Leerink Partners Outperform
2024-07-22 Hochstufung Jefferies Hold → Buy
2024-07-18 Herabstufung JP Morgan Overweight → Neutral
2024-07-10 Herabstufung Deutsche Bank Buy → Hold
2024-06-27 Herabstufung Wolfe Research Outperform → Peer Perform
2024-06-25 Herabstufung Guggenheim Buy → Neutral
2024-06-03 Fortgesetzt Jefferies Hold
2024-05-01 Herabstufung TD Cowen Buy → Hold
2023-12-14 Eingeleitet Guggenheim Buy
2023-12-13 Eingeleitet Wolfe Research Outperform
2023-12-12 Hochstufung BofA Securities Underperform → Neutral
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-05-10 Eingeleitet Barclays Overweight
2023-03-31 Eingeleitet Stephens Overweight
2023-02-02 Eingeleitet UBS Neutral
2022-12-14 Eingeleitet Deutsche Bank Buy
2022-08-18 Herabstufung Goldman Neutral → Sell
2022-07-25 Eingeleitet Canaccord Genuity Buy
2022-07-15 Herabstufung BofA Securities Neutral → Underperform
2022-07-15 Herabstufung William Blair Outperform → Mkt Perform
2021-10-15 Fortgesetzt Cowen Outperform
2021-09-14 Herabstufung BofA Securities Buy → Neutral
2021-03-15 Eingeleitet William Blair Outperform
2020-12-02 Eingeleitet Goldman Neutral
2020-09-09 Eingeleitet Morgan Stanley Overweight
2020-07-10 Eingeleitet Stifel Buy
2020-03-05 Eingeleitet Guggenheim Buy
2020-01-07 Eingeleitet Citigroup Buy
2019-10-07 Eingeleitet BofA/Merrill Buy
2019-10-07 Eingeleitet Cowen Outperform
2019-10-07 Eingeleitet JP Morgan Overweight
2019-09-24 Eingeleitet Evercore ISI Outperform
Alle ansehen

10 X Genomics Inc Aktie (TXG) Neueste Nachrichten

pulisher
03:00 AM

Advanced analytics toolkit walkthrough for 10x Genomics Inc.July 2025 Decliners & Momentum Based Trading Signals - newser.com

03:00 AM
pulisher
Oct 13, 2025

Is 10x Genomics Inc. stock dividend yield sustainableQuarterly Market Review & Community Consensus Trade Signals - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What’s the recovery path for long term holders of 10x Genomics Inc. - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is 10x Genomics Inc. stock entering bullish territoryJuly 2025 Drop Watch & Daily Market Momentum Tracking - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is 10x Genomics Inc. stock ready for a breakoutTrade Volume Report & Scalable Portfolio Growth Methods - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is 10x Genomics Inc. stock supported by strong fundamentals2025 Technical Overview & Safe Capital Growth Tips - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How geopolitical tensions affect 10x Genomics Inc. stock2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Using flow based indicators on 10x Genomics Inc.Market Trend Summary & Technical Confirmation Trade Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Single-cell Analysis Market to Reach USD 12.29 Billion by 2032, Driven by Expanding Oncology Research and Advanced Genomics – SNS Insider - GlobeNewswire Inc.

Oct 13, 2025
pulisher
Oct 12, 2025

Is 10x Genomics Inc. (1KJ) stock bottoming after sell off2025 Trade Ideas & Real-Time Stock Price Movement Reports - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

10X Genomics Experiences Evaluation Revision Amidst Market Dynamics and Performance Challenges - Markets Mojo

Oct 12, 2025
pulisher
Oct 11, 2025

10x Genomics (NASDAQ:TXG) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025 - Eastern Progress

Oct 11, 2025
pulisher
Oct 10, 2025

10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know - Yahoo Finance

Oct 10, 2025
pulisher
Oct 10, 2025

Trifecta Capital Advisors LLC Makes New $338,000 Investment in 10x Genomics $TXG - MarketBeat

Oct 10, 2025
pulisher
Oct 09, 2025

10x Genomics To Report Third Quarter 2025 Financial Results On November 6, 2025 - Barchart.com

Oct 09, 2025
pulisher
Oct 09, 2025

Can 10x Genomics Inc. stock deliver surprise earnings beatWeekly Profit Summary & Safe Entry Trade Reports - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Brown Capital Management Small Company Fund Sold 10x Genomics (TXG) Due to Fundamental Concerns - MSN

Oct 08, 2025
pulisher
Oct 08, 2025

10X Genomics Hits Day Low of $11.54 Amid Price Pressure - Markets Mojo

Oct 08, 2025
pulisher
Oct 07, 2025

10x Genomics (NASDAQ:TXG) Trading Down 7.6%What's Next? - MarketBeat

Oct 07, 2025
pulisher
Oct 06, 2025

Why 10x Genomics Inc. (1KJ) stock stays on top picksWall Street Watch & Safe Capital Growth Tips - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

How to use a screener to detect 10x Genomics Inc. breakoutsTrade Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Public Employees Retirement System of Ohio Raises Position in 10x Genomics $TXG - MarketBeat

Oct 05, 2025
pulisher
Oct 04, 2025

10x Genomics (NASDAQ:TXG) Upgraded to "Buy" at Wall Street Zen - MarketBeat

Oct 04, 2025
pulisher
Oct 03, 2025

61,470 Shares in 10x Genomics $TXG Purchased by Lecap Asset Management Ltd. - MarketBeat

Oct 03, 2025
pulisher
Oct 02, 2025

What analysts say about 10x Genomics Inc stockInstitutional Holding Changes & Small Investment Trading Plans - earlytimes.in

Oct 02, 2025
pulisher
Oct 02, 2025

4 Best Genetic Sequencing Stocks To Buy in 2025 - The Motley Fool

Oct 02, 2025
pulisher
Oct 02, 2025

Wealth Enhancement Advisory Services LLC Increases Stock Holdings in 10x Genomics $TXG - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

10x Genomics (NASDAQ:TXG) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Oct 02, 2025
pulisher
Oct 01, 2025

Pattern recognition hints at 10x Genomics Inc. upside2025 Trading Volume Trends & High Accuracy Swing Trade Signals - newser.com

Oct 01, 2025
pulisher
Oct 01, 2025

10x Genomics Aims For Growth Despite Funding Uncertainty - Finimize

Oct 01, 2025
pulisher
Sep 30, 2025

Is 10x Genomics Inc. a candidate for recovery play2025 Macro Impact & Weekly Watchlist for Consistent Profits - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Why 10x Genomics Inc. (1KJ) stock is listed among top recommendationsExit Point & Intraday High Probability Setup Alerts - newser.com

Sep 30, 2025
pulisher
Sep 28, 2025

10x Genomics Inc 1KJ Stock Analysis and ForecastFundamental Stock Analysis & Small Investment Growth Tips - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

What analysts say about 10x Genomics Inc 1KJ stockChart Pattern Recognition & Exceptional Capital Investment - Early Times

Sep 27, 2025
pulisher
Sep 24, 2025

10x Genomics (TXG): Is the Market Overlooking the Company's True Value? - simplywall.st

Sep 24, 2025
pulisher
Sep 23, 2025

78,249 Shares in 10x Genomics $TXG Purchased by Counterpoint Mutual Funds LLC - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

10x Genomics $TXG Shares Sold by Assenagon Asset Management S.A. - MarketBeat

Sep 23, 2025
pulisher
Sep 22, 2025

Pallas Capital Advisors LLC Purchases 32,996 Shares of 10x Genomics $TXG - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

What institutional flow reveals about 10x Genomics Inc.Earnings Beat & Community Supported Trade Ideas - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

Goldman Sachs Group Inc. Has $5.63 Million Holdings in 10x Genomics $TXG - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

10x Genomics (NASDAQ:TXG) Receives Sell (E+) Rating from Weiss Ratings - MarketBeat

Sep 20, 2025
pulisher
Sep 19, 2025

Risk Hedge: Does 10x Genomics Inc. offer margin of safety2025 Earnings Impact & Growth Focused Investment Plans - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Kera Capital Partners Inc. Buys Shares of 31,018 10x Genomics $TXG - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Acadian Asset Management LLC Acquires 254,607 Shares of 10x Genomics $TXG - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Investment Report: Does Future FinTech Group Inc have consistent dividend growthJuly 2025 Outlook & Precise Swing Trade Entry Alerts - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Insider Trends: Is 10x Genomics Inc. stock a good pick for beginners2025 Key Lessons & Risk Controlled Swing Alerts - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Layoff Watch: Can 10x Genomics Inc stock outperform in a bear market2025 Market Overview & Comprehensive Market Scan Reports - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Grows Stock Position in 10x Genomics $TXG - MarketBeat

Sep 19, 2025
pulisher
Sep 18, 2025

Breakouts Watch: Can 10x Genomics Inc. sustain earnings growth2025 Price Momentum & Verified High Yield Trade Plans - خودرو بانک

Sep 18, 2025

Finanzdaten der 10 X Genomics Inc-Aktie (TXG)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

10 X Genomics Inc-Aktie (TXG) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Taich Adam
Chief Financial Officer
Aug 22 '25
Sale
13.79
22,315
307,657
309,273
Hindson Benjamin J.
See Remarks
Aug 22 '25
Sale
13.79
7,486
103,209
440,888
$11.90
price down icon 2.86%
$28.00
price up icon 0.14%
$34.62
price up icon 4.21%
$24.81
price up icon 2.78%
$29.92
price up icon 1.49%
health_information_services WAY
$36.62
price up icon 1.26%
Kapitalisierung:     |  Volumen (24h):